Prosight Management LP 13D/13G Filings for ORIC Pharmaceuticals, Inc. (ORIC)

Prosight Management LP 13D and 13G filings for ORIC Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-13
09:26 am
Sale		 2023-12-31 13G ORIC Pharmaceuticals, Inc.
ORIC		 Prosight Management LP 1,578,263
2.900%		 -702,515decrease
(-30.80%)		 Filing
2023-06-09
8:15 pm
Purchase		 2023-05-31 13G ORIC Pharmaceuticals, Inc.
ORIC		 Prosight Management LP 2,280,778
5.100%		 2,280,778increase
(New Position)		 Filing